Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy ― Insights From the J-MINUET Study ―

Authors :: Minoru Wake
Shigeru Oshima
Yoshihiko Miyamoto
Y Hashimoto
Tevfik F Ismail
Hiroshi Funayama
Teruo Inoue
Hideo Izawa
Yukio Ozaki
Kenichi Tsujita
Nobuaki Kokubu
Junya Ako
Kengo Tanabe
Toshiaki Mano
Yasuhiro Morita
Satoru Suwa
Atsunori Okamura
Kazuteru Fujimoto
Wataru Shimizu
Atsushi Hirohata
Satoshi Yasuda
Mafumi Owa
Tetsuya Tobaru
Shiro Uemura
Kazuoki Dai
Kazuo Kimura
Kunihiro Nishimura
Masaharu Ishihara
Hiroshi Takahashi
Yoshihiko Saito
Takashi Morita
Teruo Noguchi
Shino Kan
Takashi Muramatsu
Ken Kozuma
Koichi Nakao
Hisao Ogawa
Yoshisato Shibata
Keijiro Saku
Source :: Circulation Journal. 85:1710-1718
Publication Year :: 2021
Publisher :: Japanese Circulation Society, 2021.
Abstract: BACKGROUND The impact of chronic kidney disease (CKD) on long-term outcomes following acute myocardial infarction (AMI) in the era of modern primary PCI with optimal medical therapy is still in debate.Methods and Results:A total of 3,281 patients with AMI were enrolled in the J-MINUET registry, with primary PCI of 93.1% in STEMI. CKD stage on admission was classified into: no CKD (eGFR ≥60 mL/min/1.73 m2); moderate CKD (60>eGFR≥30 mL/min/1.73 m2); and severe CKD (eGFR

Tools